Product NDC: | 0603-5763 |
Proprietary Name: | Spironolactone |
Non Proprietary Name: | spironolactone |
Active Ingredient(s): | 25 mg/1 & nbsp; spironolactone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0603-5763 |
Labeler Name: | Qualitest Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040750 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060829 |
Package NDC: | 0603-5763-10 |
Package Description: | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5763-10) |
NDC Code | 0603-5763-10 |
Proprietary Name | Spironolactone |
Package Description | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5763-10) |
Product NDC | 0603-5763 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | spironolactone |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20060829 |
Marketing Category Name | ANDA |
Labeler Name | Qualitest Pharmaceuticals |
Substance Name | SPIRONOLACTONE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |